πŸ‡ΊπŸ‡Έ FDA
Patent

US 8466282

Heterocyclic compound and use thereof

granted A61PA61P13/12A61P43/00

Quick answer

US patent 8466282 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P13/12, A61P43/00, A61P9/00, A61P9/04